This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Boston University. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Huishan Li: Innovator in Synthetic Gene Expression Systems
Introduction
Huishan Li is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of synthetic gene expression systems, with a focus on chimeric antigen receptor (CAR) modulation. His innovative work has led to the development of technologies that have the potential to treat various diseases and disorders.
Latest Patents
Huishan Li holds 4 patents, with his latest patent focusing on regulated synthetic gene expression systems. This technology is directed towards CAR polypeptides and systems that comprise repressible proteases. By utilizing a specific protease inhibitor, the activity of these CAR polypeptides and the cells that contain them can be modulated. This advancement opens new avenues for therapeutic applications in treating a range of medical conditions.
Career Highlights
Li is affiliated with Boston University, where he continues to push the boundaries of research in synthetic biology. His work is characterized by a commitment to innovation and a desire to improve health outcomes through advanced biotechnological solutions.
Collaborations
Throughout his career, Huishan Li has collaborated with notable colleagues, including Elliot Parker Tague and Wilson W Wong. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking technologies.
Conclusion
Huishan Li's contributions to synthetic gene expression systems exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.